Non Invasive Ventilation Niv

4

Review clinical trials related to Non Invasive Ventilation Niv. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Impact of Home Non Invasive Ventilation in Patients With Chronic Obstructive Pulmonary Disease Discharged From Assiut University Hospital

This study aims to evaluate the impact of long-term home non-invasive ventilation (NIV) on patients with COPD

Participants needed: 40
Trial details
Age: 18-80Biological sex: AllType: InterventionalSponsor: Assiut UniversityUpdated: Sep 30, 2025
Eligibility criteria

Patients more than 18 year old. [+2]

Other significant respiratory disorders (e.g,history suggestive OSA, Body Mass I... [+7]

Status: Not yet recruiting

Dynamic Impact of NIV on Diaphragmatic Ultrasound in Patients With Amyotrophic Lateral Sclerosis

The goal of this pilot observational study is to learn about the dynamic impact of the non invasive ventilation on the diaphragm in patient with amyotrophic lateral sclerosis. The main question it aims to answer : can diaphragmatic ultrasound detect differences in diaphragmatic motion (diaphragmactic excursion and diaphragmatic thickening between spontaneous breathing and non-invasive ventilation ? Participants will receive diaphragmatic ultrasound assessments both under spontaneous breathing and during non-invasive ventilation on their day hospital evaluation for ventilatory support.

Participants needed: 20
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: University Hospital, GrenobleUpdated: Sep 12, 2025Locations: 1
Eligibility criteria

Adult patient (≥18 years old) [+2]

Continuous (24-hour) non-invasive ventilation [+2]

Status: Not yet recruiting

Value of Volume Oxygenation Index to Detect Early Failure of Non-invasive Ventilation in Acute Exacerbation of Chronic Obstructive Pulmonary Disease

Non-invasive ventilation (NIV) is an evidence-based treatment for patients with acute respiratory failure due to an exacerbation of Chronic Obstructive Pulmonary Disease (COPD). In patients with COPD and acute hypercapnic respiratory failure, NIV improves gas exchange, reduces the work of breathing, and decreases the length of hospital stay and mortality \[1\]. Furthermore, when compared to invasive ventilation, NIV leads to fewer complications, such as ventilator-related infections \[2\]. These findings have resulted in guideline recommendations for the use of NIV in acute respiratory failure due to an exacerbation of COPD \[3\].NIV failure has been defined as the need for endotracheal intubation (ETI) or death. Its rate varies greatly between 5% and 60%, depending on numerous factors \[4\]. The Volume Oxygenation (VOX) index, initially developed to predict treatment failure of high flow nasal cannula therapy, has demonstrated the ability to estimate early increases in respiratory drive. Within the first 2 h, the VOX index exhibits a discriminative potential of 0.88 (95 % CI 0.79-0.97) in predicting HFNC failure \[5\]. Based on this premise, we hypothesize that the VOX index could be a predictive tool for NIV treatment failure.

Participants needed: 190
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Assiut UniversityUpdated: Jul 20, 2025
Eligibility criteria

All patients diagnosed with COPD admitted to the respiratory ICU for NIV.

Patients indicated for urgent intubation

Status: Recruiting

Music Therapy During NIV Implantation in Pediatric Intensive Care Units

Non-invasive ventilation makes it possible to avoid intubation and improve patients' quality of life. However, pain is associated with discomfort and could lead to failure of this technique. The aim of this study is to measure the effectiveness of music therapy on pain levels during non-invasive ventilation in critically ill children. To this end, a pain score (Face Legs Activity Cry Consolability FLACC) will be assessed by raters blinded to the randomization arm during NIV initiation. The FLACC score will be compared before and during implementation of NIV between two groups: a control group (without music therapy) and an experimental group (with music therapy).

Participants needed: 88
Trial details
Age: Up to 17Biological sex: AllType: InterventionalSponsor: University Hospital, MontpellierUpdated: Jul 1, 2025Locations: 1
Eligibility criteria

Children aged 0 to 17 inclusive [+2]

- Severe deafness [+8]